Neuralink Leads Braintech Surge with Record $650 Million Funding Round
Elon Musk’s Neuralink secures the largest funding in brain-computer interface history, as investor interest in neurotechnology continues to grow.
Neuralink, the brain implant company founded by Elon Musk, has officially closed a $650 million Series E funding round. This major investment pushes Neuralink’s valuation to $9 billion and marks the largest single raise for any brain-computer interface startup to date.
Since its launch in 2016, Neuralink has now raised $1.3 billion. The latest funding came from major investors including Ark Investment Management, DFJ Growth, Founders Fund, Lightspeed Venture Partners, Sequoia Capital, Qatar Investment Authority, and several others.
Neuralink’s technology is designed to help people with severe neurological conditions. Currently, five patients with serious paralysis are using Neuralink implants to control both digital and physical devices using only their thoughts. The company says this is a significant step toward restoring independence for people with disabilities.
The device works by detecting and processing brain signals through a chip implanted in the skull. These signals can then be sent to a smartphone or computer, allowing users to interact with the world in new ways. Neuralink’s device is now entering clinical trials, marking a key phase in its development.
Advertisement
Multiplier | The World's Leading Global Human Platform
Multiplier is a leading global employment platform that manages employment, payroll & compliance for International Teams. Multiplier makes it easy to hire, onboard, manage, and pay employees and contractors around the world. We offer end-to-end global employee management – All in one place!
While Neuralink is leading in funding and development, other companies in the braintech field are also attracting strong investor interest.
Science Corp., based in Alameda, California, is developing devices to help restore vision, movement, and cognition. The company raised $104 million in its most recent funding round, bringing its total raised to $177.3 million since launching in 2021.
In China, Stairway Medical secured $48 million in a Series B round earlier this year. It’s reportedly the largest investment ever for a brain-computer interface company in the country.
Another competitor, Paradromics, based in Austin, Texas, recently completed its first human surgery using its Connexus Brain-Computer Interface. Founded in 2015, Paradromics has raised $108.4 million to date, with backing from investors such as DARPA, Fusion Fund, and FJ Labs.
With Neuralink setting new records and other startups advancing quickly, braintech is entering a period of rapid growth and innovation. The surge in funding shows growing confidence in the potential of neural interface technology to transform healthcare and human interaction.